Outcome of early short-course corticosteroids in hospitalized patients with coronavirus disease-2019 (COVID-19): A report from a Saudi Arabian hospital.

IF 1.9 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Journal of Family and Community Medicine Pub Date : 2021-05-01 Epub Date: 2021-05-08 DOI:10.4103/jfcm.jfcm_69_21
Salma Y Al-Bahrani, Amal S Al-Shammari, Maha J Al-Otaibi, Zubair R Ahmed
{"title":"Outcome of early short-course corticosteroids in hospitalized patients with coronavirus disease-2019 (COVID-19): A report from a Saudi Arabian hospital.","authors":"Salma Y Al-Bahrani,&nbsp;Amal S Al-Shammari,&nbsp;Maha J Al-Otaibi,&nbsp;Zubair R Ahmed","doi":"10.4103/jfcm.jfcm_69_21","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The efficacy of corticosteroid use in patients with acute respiratory illness due to coronavirus disease-2019 (COVID-19) is unclear. In this study, we describe the clinical course of COVID-19 patients who received early course of corticosteroid treatment in patients with severe respiratory distress secondary to COVID-19.</p><p><strong>Materials and methods: </strong>The clinical course of 30 COVID-19 patients admitted to King Fahad Military Medical Complex in Dhahran from the period of late March 2020 till June 2020 was assessed and described. All the 30 patients received steroids. Data on demographics, medical history, laboratory findings, chest radiology, medication use, and clinical outcomes were extracted from patients' records. Data was entered and analyzed with SPSS software.</p><p><strong>Results: </strong>A total of 30 patients admitted with COVID-19 were included. The mean age 52.53 years (SD=16.31) with a range from 22-98 years; 73.3% were males. About two-thirds of the patients at least had comorbidities; most common were diabetes (46.7%) and hypertension (46.7%), and chronic heart disease (16.7%). About 57% patients had fever, cough, and shortness of breath. The median C-reactive protein (CRP) level was 87.5 mg/dL (IQR 45.0 - 165.65); 46.7% had CRP levels >120 mg/dL. The median white blood cell, lymphocytes, and platelet counts were 4.39, 1.05, and 212 K/μL, respectively. All the patients received corticosteroids; 17 (56.7%) patients were given IV methylprednisolone and 13 (43.3%) received dexamethasone tablets. Of the total patients, 13 (43.3%) patients developed acute respiratory distress syndrome (ARDS); 17 (56.7%) required oxygen, 10 (33.3%) were admitted to Intensive Care Unit (ICU), and 7 (23.3%) required mechanical ventilation. All the patients improved and were discharged home well.</p><p><strong>Conclusion: </strong>Early use of oral corticosteroids in patients with higher CRP levels may lead to better outcomes and may lower risk of transfer to ICU and use of mechanical ventilation.</p>","PeriodicalId":46862,"journal":{"name":"Journal of Family and Community Medicine","volume":"28 2","pages":"125-128"},"PeriodicalIF":1.9000,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/dd/23/JFCM-28-125.PMC8213107.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Family and Community Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jfcm.jfcm_69_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/5/8 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 1

Abstract

Background: The efficacy of corticosteroid use in patients with acute respiratory illness due to coronavirus disease-2019 (COVID-19) is unclear. In this study, we describe the clinical course of COVID-19 patients who received early course of corticosteroid treatment in patients with severe respiratory distress secondary to COVID-19.

Materials and methods: The clinical course of 30 COVID-19 patients admitted to King Fahad Military Medical Complex in Dhahran from the period of late March 2020 till June 2020 was assessed and described. All the 30 patients received steroids. Data on demographics, medical history, laboratory findings, chest radiology, medication use, and clinical outcomes were extracted from patients' records. Data was entered and analyzed with SPSS software.

Results: A total of 30 patients admitted with COVID-19 were included. The mean age 52.53 years (SD=16.31) with a range from 22-98 years; 73.3% were males. About two-thirds of the patients at least had comorbidities; most common were diabetes (46.7%) and hypertension (46.7%), and chronic heart disease (16.7%). About 57% patients had fever, cough, and shortness of breath. The median C-reactive protein (CRP) level was 87.5 mg/dL (IQR 45.0 - 165.65); 46.7% had CRP levels >120 mg/dL. The median white blood cell, lymphocytes, and platelet counts were 4.39, 1.05, and 212 K/μL, respectively. All the patients received corticosteroids; 17 (56.7%) patients were given IV methylprednisolone and 13 (43.3%) received dexamethasone tablets. Of the total patients, 13 (43.3%) patients developed acute respiratory distress syndrome (ARDS); 17 (56.7%) required oxygen, 10 (33.3%) were admitted to Intensive Care Unit (ICU), and 7 (23.3%) required mechanical ventilation. All the patients improved and were discharged home well.

Conclusion: Early use of oral corticosteroids in patients with higher CRP levels may lead to better outcomes and may lower risk of transfer to ICU and use of mechanical ventilation.

2019冠状病毒病(COVID-19)住院患者早期短期皮质类固醇治疗的结果:来自沙特阿拉伯一家医院的报告
背景:皮质类固醇治疗冠状病毒病-2019 (COVID-19)急性呼吸系统疾病的疗效尚不清楚。在本研究中,我们描述了COVID-19继发性严重呼吸窘迫患者早期接受皮质类固醇治疗的COVID-19患者的临床过程。材料与方法:对2020年3月下旬至2020年6月在达赫兰法赫德国王军事医疗中心收治的30例新冠肺炎患者的临床病程进行评估和描述。所有30名患者都接受了类固醇治疗。从患者记录中提取了人口统计学、病史、实验室结果、胸部放射学、药物使用和临床结果等数据。用SPSS软件进行数据录入和分析。结果:共纳入30例新冠肺炎住院患者。平均年龄52.53岁(SD=16.31),年龄范围22 ~ 98岁;73.3%为男性。大约三分之二的患者至少有合并症;最常见的是糖尿病(46.7%)、高血压(46.7%)和慢性心脏病(16.7%)。约57%的患者有发热、咳嗽和呼吸短促。中位c反应蛋白(CRP)水平为87.5 mg/dL (IQR为45.0 ~ 165.65);46.7%的患者CRP水平> 120mg /dL。白细胞、淋巴细胞和血小板的中位数分别为4.39、1.05和212 K/μL。所有患者均接受皮质类固醇治疗;静脉注射甲基强的松龙17例(56.7%),地塞米松片13例(43.3%)。13例(43.3%)患者出现急性呼吸窘迫综合征(ARDS);需吸氧17例(56.7%),重症监护病房10例(33.3%),机械通气7例(23.3%)。所有患者均好转出院。结论:CRP水平较高的患者早期使用口服皮质激素可获得更好的预后,并可降低转入ICU和使用机械通气的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Family and Community Medicine
Journal of Family and Community Medicine PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
4.00
自引率
3.70%
发文量
20
审稿时长
37 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信